Neurocrine spotlights challenges of congenital adrenal hyperplasia patients with ‘What the C@H?!’ campaign
Neurocrine Biosciences’ newest educational campaign wants frustrated congenital adrenal hyperplasia patients to ask, “What the C@H?!” Neurocrine unveiled the campaign this week, not long after reporting positive results for a pair of phase 3 studies of its …